Clontech

Palo Alto, United States Founded: 1984 • Age: 42 yrs Acquired By Takara Bio
Reagents, instruments, and services for life science industries are provided.
Request Access

About Clontech

Clontech is a company based in Palo Alto (United States) founded in 1984 was acquired by Takara Bio in July 2005.. Clontech offers products and services including Kits, Reagents, and Instruments. Clontech operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others.

  • Headquarter Palo Alto, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Takara Bio Usa, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Takara Bio

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Takara Bio

    (Jul 01, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Clontech

Clontech offers a comprehensive portfolio of products and services, including Kits, Reagents, and Instruments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tools for gene discovery and nucleic acid purification

Substances for PCR and CRISPR applications

Devices for single-cell sequencing and analysis

Funding Insights of Clontech

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 1999 Amount Series A - Clontech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Clontech

Clontech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Takara Bio and Summit Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Summit Partners is recognized as a growth equity investment firm.
Founded Year Domain Location
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Clontech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Clontech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Clontech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Clontech

Clontech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assay kits for ultra-sensitive biomarker detection are developed.
domain founded_year HQ Location
Primary antibodies and instruments for immunohistochemistry are manufactured.
domain founded_year HQ Location
Merck is engaged in science and technology solutions globally.
domain founded_year HQ Location
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
domain founded_year HQ Location
RNA-sequencing transcriptome kits for health data analysis are developed.
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Clontech

Frequently Asked Questions about Clontech

When was Clontech founded?

Clontech was founded in 1984 and raised its 1st funding round 15 years after it was founded.

Where is Clontech located?

Clontech is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

What does Clontech do?

Clontech was founded in 1984 in Palo Alto, United States, within the life science sector. Reagents, instruments, and services are supplied for research applications. Products encompass PCR reagents, RT enzymes, library construction kits, cloning kits, and nucleic acidprotein purification tools. Services include gene discovery, protein analysis, plant and food research, and RNAi studies. Acquisition by Takara Bio was completed on July 1, 2005.

Who are the top competitors of Clontech?

Clontech's top competitors include Neogen, Biocare Medical and Merck.

What products or services does Clontech offer?

Clontech offers Kits, Reagents, and Instruments.

Who are Clontech's investors?

Clontech has 2 investors. Key investors include Takara Bio, and Summit Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available